Synthetic Biologics Reports First Quarter 2022 Operational
-Encouraging data further supports the development of novel oncolytic adenovirus (OV) platform; Announced a peer-reviewed publication highlighting positive...
Source: globenewswire.com
Nyse Syn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse Syn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Syn Today - Breaking & Trending Today
Synthetic Biologics Announces Formation of Scientific
Scientific Advisory Board of leading experts in oncolytic adenoviruses and gene therapies strengthens transformative clinical development strategy and...
Source: globenewswire.com
Synthetic Biologics Announces Management Transitions in
-Frank Tufaro, Ph.D., appointed as Chief Operating Officer of Synthetic Biologics, transitioning from Chief Operating Officer of VCN Biosciences- -Manel...
Source: globenewswire.com
Synthetic Biologics Reports 2021 Year End Operational
-Completed acquisition of VCN Biosciences, expanding pipeline into oncology- -VCN-01 received Orphan Drug Designation for retinoblastoma from the U.S....
Source: globenewswire.com